We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effect of expansion of human umbilical cord blood CD34 + cells on neurotrophic and angiogenic factor expression and function.
- Authors
Watt, Ashalyn P.; Kirkland, Mark; Nekkanti, Lakshmi; Pham, Yen; McDonald, Courtney; Malhotra, Atul; Moeneclaey, Guy; Miller, Suzanne L.; Jenkin, Graham
- Abstract
The use of CD34 + cell-based therapies has largely been focused on haematological conditions. However, there is increasing evidence that umbilical cord blood (UCB) CD34 + -derived cells have neuroregenerative properties. Due to low cell numbers of CD34 + cells present in UCB, expansion is required to produce sufficient cells for therapeutic purposes, especially in adults or when frequent applications are required. However, it is not known whether expansion of CD34 + cells has an impact on their function and neuroregenerative capacity. We addressed this knowledge gap in this study, via expansion of UCB-derived CD34 + cells using combinations of LDL, UM171 and SR-1 to yield large numbers of cells and then tested their functionality. CD34 + cells expanded for 14 days in media containing UM171 and SR-1 resulted in over 1000-fold expansion. The expanded cells showed an up-regulation of the neurotrophic factor genes BDNF, GDNF, NTF-3 and NTF-4, as well as the angiogenic factors VEGF and ANG. In vitro functionality testing showed that these expanded cells promoted angiogenesis and, in brain glial cells, promoted cell proliferation and reduced production of reactive oxygen species (ROS) during oxidative stress. Collectively, this study showed that our 14-day expansion protocol provided a robust expansion that could produce enough cells for therapeutic purposes. These expanded cells, when tested in in vitro, maintained functionality as demonstrated through promotion of cell proliferation, attenuation of ROS production caused by oxidative stress and promotion of angiogenesis.
- Subjects
ANGOLA; CORD blood; VASCULAR endothelial growth factors; CD34 antigen; REACTIVE oxygen species; HEMATOPOIETIC stem cells
- Publication
Cell & Tissue Research, 2022, Vol 388, Issue 1, p117
- ISSN
0302-766X
- Publication type
Article
- DOI
10.1007/s00441-022-03592-2